Skip to content
Screener

Tandem Diabetes Care TNDM Supplies and other — Sales

Other product segments

Pump
$114.65M+2.5%

Similar metrics at other companies

Barnes & Noble Education logo
BNEDProduct and Other Sales — Sales
$220.15M-5.5%
MGP Ingredients logo
MGPIBiofuel and other — Sales
$1.12M
La-Z-Boy logo
LZBOther — Sales
$63.58M+33.8%
Astronics logo
ATROOther — Sales
$5.62M-32.4%
Boise Cascade logo
BCCOther — Sales
$5.6M-12.5%
Sysco logo
SYYOther — Sales
$677M+6.3%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.56B+128%
Enterprise value$2.23B+109%
P/S1.5×+0.8×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Pump$114,652$111,871$225,078$213,962
Supplies and other139,908128,807276,703261,138
Total Sales$254,560$240,678$501,781$475,100

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's supplies and other — sales?
Tandem Diabetes Care (TNDM) reported supplies and other — sales of $139.91M in Q2 2026.
How has Tandem Diabetes Care's supplies and other — sales changed year-over-year?
Tandem Diabetes Care's supplies and other — sales increased by 8.6% year-over-year, from $128.81M to $139.91M.
What is the long-term trend for Tandem Diabetes Care's supplies and other — sales?
Over 3 years (2022 to 2025), Tandem Diabetes Care's supplies and other — sales has grown at a 13.9% compound annual growth rate (CAGR), from $372.86M to $550.57M.
What does supplies and other — sales mean?
This metric represents the revenue generated from the sale of recurring consumables, accessories, and associated services required to support the primary hardware platform. It serves as a critical indicator of the installed base size and long-term customer retention, as these items are essential for the ongoing operation of the company's medical devices. Growth in this segment reflects the recurring nature of the business model and the deepening of the relationship with the existing patient population.

Ask your AI about Tandem Diabetes Care's supplies and other — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude